Home > Income Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Revenue

    Back to Income Statement
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹198 Cr₹154 Cr₹140 Cr₹114 Cr₹69 Cr

What is the latest Revenue of KILITCH DRUGS (INDIA) ?

The latest Revenue ratio of KILITCH DRUGS (INDIA) is ₹198 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹198 Cr
Mar2024₹154 Cr
Mar2023₹140 Cr
Mar2022₹114 Cr
Mar2021₹69 Cr

How is Revenue of KILITCH DRUGS (INDIA) Trending?

Years Revenue % Change
Mar2025 ₹198 Cr
28.47
Mar2024 ₹154 Cr
10.58
Mar2023 ₹140 Cr
22.20
Mar2022 ₹114 Cr
66.71
Mar2021 ₹69 Cr -

Compare Revenue of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹601.7 Cr 1.5% 0.6% 1.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,019.0 Cr -3.5% -5.4% -3.2% Stock Analytics
DIVIS LABORATORIES ₹168,752.0 Cr -3.6% 0.2% 11.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,542.0 Cr -0.5% 5.9% 20.3% Stock Analytics
CIPLA ₹115,883.0 Cr -1.8% -4.8% -1.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,024.7 Cr -1.7% -7.3% -12.1% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

1.5%

0.6%

1.3%

SENSEX

-1.9%

-2.2%

7.4%


You may also like the below Video Courses